![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Aarti Drugs Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Ranitidine hydrochloride, (Form II), supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2001-401 - Rev 01
This Chemical Type CEP, issued on October 01, 2004, remains in force until February 24, 2009, ensuring its reliability within the pharmaceutical industry.
Substance Number 946 associated with this CEP further emphasizes